Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tuberous Sclerosis | 99 | 2023 | 1030 | 14.070 |
Why?
|
TOR Serine-Threonine Kinases | 42 | 2023 | 2102 | 4.270 |
Why?
|
Spastic Paraplegia, Hereditary | 15 | 2024 | 156 | 3.570 |
Why?
|
Autistic Disorder | 21 | 2023 | 1164 | 3.530 |
Why?
|
Tumor Suppressor Proteins | 33 | 2023 | 2845 | 2.520 |
Why?
|
Neurons | 41 | 2024 | 9336 | 2.410 |
Why?
|
Induced Pluripotent Stem Cells | 11 | 2023 | 1702 | 2.270 |
Why?
|
Adaptor Protein Complex 4 | 9 | 2023 | 37 | 2.240 |
Why?
|
Purkinje Cells | 6 | 2021 | 247 | 1.820 |
Why?
|
Epilepsy | 24 | 2023 | 3289 | 1.790 |
Why?
|
Cilia | 4 | 2021 | 466 | 1.790 |
Why?
|
Survival of Motor Neuron 1 Protein | 6 | 2018 | 64 | 1.700 |
Why?
|
Sturge-Weber Syndrome | 7 | 2021 | 84 | 1.660 |
Why?
|
Seizures | 15 | 2023 | 2829 | 1.510 |
Why?
|
Cerebellum | 8 | 2018 | 1515 | 1.400 |
Why?
|
Brain | 62 | 2023 | 26345 | 1.390 |
Why?
|
GTPase-Activating Proteins | 3 | 2022 | 498 | 1.350 |
Why?
|
Chromosome Disorders | 9 | 2023 | 516 | 1.310 |
Why?
|
Axons | 10 | 2022 | 1689 | 1.210 |
Why?
|
Sirolimus | 11 | 2020 | 1559 | 1.190 |
Why?
|
Rett Syndrome | 4 | 2018 | 165 | 1.160 |
Why?
|
Muscular Atrophy, Spinal | 5 | 2018 | 258 | 1.150 |
Why?
|
Spasms, Infantile | 6 | 2021 | 301 | 1.150 |
Why?
|
ARNTL Transcription Factors | 2 | 2017 | 98 | 1.080 |
Why?
|
Behavior, Animal | 6 | 2020 | 1891 | 1.050 |
Why?
|
Signal Transduction | 30 | 2023 | 23355 | 1.040 |
Why?
|
Hamartoma Syndrome, Multiple | 5 | 2023 | 111 | 1.010 |
Why?
|
Chromosome Deletion | 10 | 2023 | 1402 | 0.980 |
Why?
|
Autophagy | 7 | 2021 | 1295 | 0.960 |
Why?
|
Pentylenetetrazole | 2 | 2021 | 69 | 0.950 |
Why?
|
Convulsants | 2 | 2021 | 70 | 0.940 |
Why?
|
Fragile X Mental Retardation Protein | 2 | 2021 | 118 | 0.910 |
Why?
|
Animals | 95 | 2023 | 168368 | 0.870 |
Why?
|
Disease Models, Animal | 27 | 2023 | 18003 | 0.840 |
Why?
|
rhoA GTP-Binding Protein | 3 | 2021 | 241 | 0.820 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 1 | 2023 | 255 | 0.790 |
Why?
|
Developmental Disabilities | 8 | 2021 | 1445 | 0.760 |
Why?
|
Chromosomes, Human, Pair 16 | 3 | 2021 | 357 | 0.760 |
Why?
|
Electroencephalography | 23 | 2022 | 6133 | 0.740 |
Why?
|
Vigabatrin | 5 | 2019 | 92 | 0.730 |
Why?
|
Child, Preschool | 72 | 2023 | 40802 | 0.700 |
Why?
|
PTEN Phosphohydrolase | 11 | 2023 | 1142 | 0.700 |
Why?
|
Corpus Callosum | 3 | 2021 | 739 | 0.690 |
Why?
|
Heat-Shock Response | 1 | 2020 | 165 | 0.690 |
Why?
|
Mice | 55 | 2023 | 81002 | 0.680 |
Why?
|
Genetic Predisposition to Disease | 9 | 2022 | 17384 | 0.670 |
Why?
|
Protein Biosynthesis | 5 | 2015 | 2131 | 0.670 |
Why?
|
Receptor, EphA1 | 3 | 2010 | 20 | 0.660 |
Why?
|
Social Isolation | 1 | 2021 | 361 | 0.640 |
Why?
|
Dendritic Spines | 3 | 2015 | 233 | 0.640 |
Why?
|
Nerve Tissue Proteins | 8 | 2023 | 4463 | 0.630 |
Why?
|
Central Nervous System Agents | 1 | 2018 | 71 | 0.630 |
Why?
|
Humans | 208 | 2024 | 739398 | 0.630 |
Why?
|
Aconitate Hydratase | 1 | 2017 | 15 | 0.620 |
Why?
|
Mutation | 28 | 2024 | 29658 | 0.600 |
Why?
|
Connective Tissue Growth Factor | 1 | 2017 | 96 | 0.580 |
Why?
|
Genetic Association Studies | 5 | 2022 | 2694 | 0.580 |
Why?
|
Nerve Net | 5 | 2021 | 2179 | 0.580 |
Why?
|
Synaptic Transmission | 2 | 2021 | 1177 | 0.580 |
Why?
|
Multiprotein Complexes | 10 | 2017 | 1122 | 0.570 |
Why?
|
Myelin Sheath | 2 | 2019 | 664 | 0.570 |
Why?
|
Anticonvulsants | 9 | 2023 | 1907 | 0.560 |
Why?
|
Lysosomal Storage Diseases, Nervous System | 1 | 2015 | 9 | 0.560 |
Why?
|
Fasting | 1 | 2022 | 1587 | 0.550 |
Why?
|
Cells, Cultured | 23 | 2021 | 19220 | 0.550 |
Why?
|
Phenotype | 21 | 2023 | 16301 | 0.550 |
Why?
|
Brain Diseases, Metabolic, Inborn | 1 | 2015 | 44 | 0.540 |
Why?
|
Models, Biological | 7 | 2021 | 9609 | 0.540 |
Why?
|
Magnetic Resonance Imaging | 27 | 2022 | 35326 | 0.530 |
Why?
|
Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2014 | 31 | 0.520 |
Why?
|
Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2015 | 55 | 0.520 |
Why?
|
Mice, Knockout | 18 | 2022 | 14558 | 0.520 |
Why?
|
Activating Transcription Factor 3 | 1 | 2015 | 54 | 0.510 |
Why?
|
Adolescent Development | 1 | 2018 | 274 | 0.510 |
Why?
|
Ataxia | 1 | 2017 | 299 | 0.510 |
Why?
|
Growth Cones | 5 | 2010 | 117 | 0.510 |
Why?
|
Cystadenoma | 1 | 2014 | 84 | 0.500 |
Why?
|
Gelsolin | 1 | 2015 | 190 | 0.500 |
Why?
|
Neuroprotective Agents | 3 | 2019 | 940 | 0.500 |
Why?
|
Neurocutaneous Syndromes | 1 | 2015 | 45 | 0.490 |
Why?
|
Social Behavior | 3 | 2018 | 1131 | 0.490 |
Why?
|
Malformations of Cortical Development | 4 | 2022 | 200 | 0.490 |
Why?
|
Motor Neurons | 3 | 2018 | 843 | 0.480 |
Why?
|
Plagiarism | 1 | 2014 | 22 | 0.480 |
Why?
|
Infant | 50 | 2023 | 34923 | 0.480 |
Why?
|
Cerebral Palsy | 4 | 2022 | 457 | 0.480 |
Why?
|
Neural Pathways | 6 | 2019 | 2976 | 0.480 |
Why?
|
Receptors, Eph Family | 4 | 2010 | 44 | 0.470 |
Why?
|
Synapses | 5 | 2018 | 1719 | 0.470 |
Why?
|
Retinitis Pigmentosa | 1 | 2017 | 387 | 0.460 |
Why?
|
Rhabdomyoma | 3 | 2008 | 57 | 0.460 |
Why?
|
Astrocytoma | 3 | 2020 | 789 | 0.460 |
Why?
|
Child | 61 | 2023 | 77033 | 0.460 |
Why?
|
DNA Repair Enzymes | 1 | 2015 | 348 | 0.460 |
Why?
|
MicroRNAs | 5 | 2018 | 3712 | 0.450 |
Why?
|
Behavior | 3 | 2015 | 561 | 0.450 |
Why?
|
Status Epilepticus | 4 | 2011 | 435 | 0.450 |
Why?
|
Child Behavior | 2 | 2018 | 836 | 0.450 |
Why?
|
Angiomatosis | 1 | 2013 | 49 | 0.450 |
Why?
|
Circadian Clocks | 1 | 2015 | 170 | 0.440 |
Why?
|
Diffusion Tensor Imaging | 12 | 2020 | 2301 | 0.430 |
Why?
|
Neural Stem Cells | 1 | 2020 | 843 | 0.430 |
Why?
|
Hemangiosarcoma | 1 | 2014 | 228 | 0.430 |
Why?
|
Genes, Duplicate | 1 | 2012 | 33 | 0.420 |
Why?
|
Child Development | 3 | 2019 | 2213 | 0.420 |
Why?
|
Nerve Fibers, Myelinated | 6 | 2015 | 964 | 0.420 |
Why?
|
Male | 102 | 2023 | 349022 | 0.410 |
Why?
|
Pluripotent Stem Cells | 4 | 2023 | 791 | 0.410 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 2012 | 657 | 0.400 |
Why?
|
Rats | 21 | 2023 | 24270 | 0.400 |
Why?
|
Child Development Disorders, Pervasive | 6 | 2014 | 616 | 0.400 |
Why?
|
Intracellular Signaling Peptides and Proteins | 5 | 2022 | 2901 | 0.390 |
Why?
|
Migraine Disorders | 1 | 2023 | 1606 | 0.390 |
Why?
|
Female | 102 | 2023 | 378853 | 0.390 |
Why?
|
Alleles | 5 | 2021 | 6942 | 0.390 |
Why?
|
Mental Disorders | 6 | 2022 | 6570 | 0.390 |
Why?
|
Evoked Potentials | 1 | 2017 | 1057 | 0.390 |
Why?
|
Protein Kinases | 3 | 2014 | 1637 | 0.390 |
Why?
|
Genetic Counseling | 1 | 2015 | 601 | 0.390 |
Why?
|
Ephrin-A1 | 2 | 2010 | 9 | 0.380 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 3 | 2009 | 433 | 0.370 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2014 | 607 | 0.370 |
Why?
|
Adolescent | 47 | 2023 | 85405 | 0.370 |
Why?
|
Central Nervous System Diseases | 1 | 2014 | 522 | 0.360 |
Why?
|
Epilepsies, Partial | 4 | 2021 | 438 | 0.360 |
Why?
|
Heart Neoplasms | 3 | 2008 | 374 | 0.360 |
Why?
|
Adolescent Behavior | 1 | 2018 | 1146 | 0.350 |
Why?
|
Neuronal Plasticity | 2 | 2016 | 1416 | 0.350 |
Why?
|
Mice, Inbred CBA | 3 | 2021 | 446 | 0.340 |
Why?
|
Genetic Testing | 5 | 2023 | 3441 | 0.340 |
Why?
|
Editorial Policies | 1 | 2014 | 446 | 0.340 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 2 | 2021 | 133 | 0.330 |
Why?
|
Neurogenesis | 4 | 2020 | 821 | 0.330 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2010 | 200 | 0.330 |
Why?
|
Stem Cells | 2 | 2020 | 3566 | 0.320 |
Why?
|
Maze Learning | 3 | 2017 | 478 | 0.320 |
Why?
|
Protein Tyrosine Phosphatases | 3 | 1995 | 470 | 0.320 |
Why?
|
Chromosomes, Human, Pair 22 | 7 | 2023 | 351 | 0.320 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2020 | 8977 | 0.310 |
Why?
|
Proteins | 8 | 2024 | 6082 | 0.310 |
Why?
|
Cognition Disorders | 4 | 2018 | 4026 | 0.310 |
Why?
|
Spasm | 1 | 2008 | 117 | 0.310 |
Why?
|
Neuropeptides | 2 | 2011 | 942 | 0.300 |
Why?
|
Memory | 1 | 2017 | 2161 | 0.300 |
Why?
|
Guanine Nucleotide Exchange Factors | 4 | 2006 | 578 | 0.300 |
Why?
|
Hippocampus | 6 | 2020 | 3657 | 0.300 |
Why?
|
Anxiety | 4 | 2023 | 4253 | 0.300 |
Why?
|
Heterozygote | 6 | 2021 | 2798 | 0.290 |
Why?
|
Nervous System Diseases | 2 | 2014 | 1621 | 0.290 |
Why?
|
DNA Copy Number Variations | 4 | 2022 | 1936 | 0.280 |
Why?
|
Gene Expression | 6 | 2021 | 7788 | 0.280 |
Why?
|
Protein Transport | 2 | 2024 | 1991 | 0.270 |
Why?
|
Germ-Line Mutation | 4 | 2021 | 1786 | 0.270 |
Why?
|
Immunosuppressive Agents | 3 | 2018 | 4143 | 0.270 |
Why?
|
Diffusion Magnetic Resonance Imaging | 7 | 2018 | 2732 | 0.270 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2014 | 1849 | 0.270 |
Why?
|
Central Nervous System | 2 | 2011 | 1362 | 0.270 |
Why?
|
Circadian Rhythm | 1 | 2017 | 2614 | 0.270 |
Why?
|
Fragile X Syndrome | 2 | 2018 | 116 | 0.260 |
Why?
|
Grooming | 2 | 2017 | 37 | 0.260 |
Why?
|
Triiodobenzoic Acids | 1 | 2005 | 123 | 0.250 |
Why?
|
Cyclin-Dependent Kinase 5 | 2 | 2020 | 112 | 0.240 |
Why?
|
Neocortex | 2 | 2020 | 401 | 0.240 |
Why?
|
Checklist | 3 | 2023 | 817 | 0.240 |
Why?
|
Quality of Life | 2 | 2023 | 12640 | 0.240 |
Why?
|
Mice, Inbred C57BL | 10 | 2021 | 21863 | 0.240 |
Why?
|
Embryo, Mammalian | 8 | 2011 | 1698 | 0.240 |
Why?
|
Anisotropy | 9 | 2019 | 1265 | 0.230 |
Why?
|
Cell Movement | 2 | 2020 | 5221 | 0.230 |
Why?
|
Lysosomes | 3 | 2021 | 900 | 0.230 |
Why?
|
Succinate-Semialdehyde Dehydrogenase | 1 | 2023 | 70 | 0.220 |
Why?
|
Genetic Variation | 3 | 2023 | 6539 | 0.210 |
Why?
|
Vocalization, Animal | 2 | 2012 | 85 | 0.210 |
Why?
|
Lissencephaly | 2 | 2020 | 38 | 0.210 |
Why?
|
Encephalitis | 3 | 2011 | 423 | 0.210 |
Why?
|
Neuropsychiatry | 2 | 2019 | 55 | 0.210 |
Why?
|
Models, Genetic | 2 | 2012 | 3493 | 0.210 |
Why?
|
Brain Diseases | 3 | 2018 | 1551 | 0.200 |
Why?
|
Mice, Transgenic | 10 | 2018 | 9734 | 0.200 |
Why?
|
Cerebral Cortex | 6 | 2019 | 5721 | 0.200 |
Why?
|
Action Potentials | 2 | 2019 | 1813 | 0.200 |
Why?
|
Tyrosine | 2 | 2006 | 1460 | 0.200 |
Why?
|
Language Development | 2 | 2019 | 187 | 0.200 |
Why?
|
Rats, Long-Evans | 3 | 2017 | 387 | 0.200 |
Why?
|
Evoked Potentials, Visual | 2 | 2015 | 427 | 0.200 |
Why?
|
RNA, Messenger | 4 | 2014 | 13002 | 0.200 |
Why?
|
Rare Diseases | 3 | 2022 | 553 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2020 | 2507 | 0.200 |
Why?
|
Genotype | 7 | 2021 | 12951 | 0.200 |
Why?
|
Papilloma | 1 | 2022 | 148 | 0.190 |
Why?
|
Endocannabinoids | 1 | 2022 | 116 | 0.190 |
Why?
|
Young Adult | 23 | 2023 | 56255 | 0.190 |
Why?
|
Angiopoietin-2 | 1 | 2021 | 167 | 0.190 |
Why?
|
Up-Regulation | 3 | 2021 | 4205 | 0.190 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2020 | 61 | 0.190 |
Why?
|
Longitudinal Studies | 14 | 2021 | 13880 | 0.190 |
Why?
|
Mice, 129 Strain | 1 | 2021 | 387 | 0.190 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2020 | 2933 | 0.180 |
Why?
|
Multiple Sclerosis | 1 | 2015 | 3065 | 0.180 |
Why?
|
Carbamazepine | 2 | 2017 | 229 | 0.180 |
Why?
|
Biomedical Research | 1 | 2016 | 3301 | 0.180 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5830 | 0.180 |
Why?
|
Image Interpretation, Computer-Assisted | 5 | 2015 | 3344 | 0.180 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2012 | 2393 | 0.180 |
Why?
|
Seizures, Febrile | 2 | 2011 | 115 | 0.180 |
Why?
|
Organic Chemicals | 1 | 2021 | 212 | 0.180 |
Why?
|
trans-Golgi Network | 1 | 2020 | 33 | 0.180 |
Why?
|
Carrier Proteins | 4 | 2011 | 5012 | 0.180 |
Why?
|
Reproducibility of Results | 13 | 2023 | 19811 | 0.180 |
Why?
|
Organoids | 2 | 2023 | 687 | 0.180 |
Why?
|
RNA, Small Interfering | 4 | 2015 | 3498 | 0.180 |
Why?
|
Benzoquinones | 1 | 2020 | 201 | 0.180 |
Why?
|
Penetrance | 1 | 2021 | 381 | 0.180 |
Why?
|
Brain Neoplasms | 4 | 2020 | 8791 | 0.180 |
Why?
|
Oxidative Stress | 3 | 2010 | 3087 | 0.170 |
Why?
|
Pathology, Molecular | 1 | 2022 | 325 | 0.170 |
Why?
|
Software | 1 | 2014 | 4423 | 0.170 |
Why?
|
Glycogen Storage Disease Type II | 1 | 1999 | 42 | 0.170 |
Why?
|
Gene Expression Regulation | 6 | 2019 | 12049 | 0.170 |
Why?
|
Cognition | 5 | 2021 | 6686 | 0.170 |
Why?
|
Blotting, Western | 6 | 2015 | 5181 | 0.170 |
Why?
|
Kidney Neoplasms | 2 | 2017 | 4189 | 0.170 |
Why?
|
Reactive Oxygen Species | 3 | 2013 | 2084 | 0.170 |
Why?
|
Excitatory Postsynaptic Potentials | 3 | 2016 | 374 | 0.170 |
Why?
|
Genes, Lethal | 1 | 2019 | 243 | 0.170 |
Why?
|
Scalp | 2 | 2019 | 376 | 0.170 |
Why?
|
Hamartoma | 1 | 2021 | 236 | 0.170 |
Why?
|
Endothelial Cells | 4 | 2022 | 3435 | 0.170 |
Why?
|
Computational Biology | 1 | 2011 | 3506 | 0.170 |
Why?
|
Survival of Motor Neuron 2 Protein | 1 | 2018 | 48 | 0.160 |
Why?
|
Lactams, Macrocyclic | 1 | 2020 | 320 | 0.160 |
Why?
|
Capillaries | 1 | 2021 | 767 | 0.160 |
Why?
|
Pedigree | 5 | 2022 | 4640 | 0.160 |
Why?
|
Phospholipase C beta | 2 | 2021 | 50 | 0.160 |
Why?
|
Excitatory Amino Acid Agents | 1 | 2017 | 23 | 0.160 |
Why?
|
Research Report | 1 | 2021 | 351 | 0.160 |
Why?
|
Cell Differentiation | 6 | 2023 | 11460 | 0.160 |
Why?
|
Gliosis | 3 | 2019 | 243 | 0.160 |
Why?
|
Visual Perception | 2 | 2018 | 1418 | 0.160 |
Why?
|
Ribosomes | 1 | 2021 | 499 | 0.160 |
Why?
|
Fluorescent Antibody Technique | 2 | 2019 | 2503 | 0.160 |
Why?
|
Microarray Analysis | 2 | 2022 | 759 | 0.150 |
Why?
|
Neonatal Screening | 1 | 2022 | 591 | 0.150 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7274 | 0.150 |
Why?
|
Thalamus | 2 | 1995 | 1020 | 0.150 |
Why?
|
World Health Organization | 1 | 2023 | 1321 | 0.150 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2023 | 1127 | 0.150 |
Why?
|
Stereotypic Movement Disorder | 1 | 2017 | 29 | 0.150 |
Why?
|
Microcephaly | 1 | 2021 | 429 | 0.150 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2020 | 435 | 0.150 |
Why?
|
Infant, Newborn | 13 | 2022 | 25470 | 0.150 |
Why?
|
Models, Neurological | 3 | 2015 | 1769 | 0.150 |
Why?
|
Phosphorylation | 8 | 2015 | 8416 | 0.150 |
Why?
|
Vesicular Transport Proteins | 1 | 2020 | 371 | 0.150 |
Why?
|
Age Factors | 6 | 2021 | 18349 | 0.140 |
Why?
|
Species Specificity | 1 | 2021 | 2480 | 0.140 |
Why?
|
Barbiturates | 1 | 2017 | 115 | 0.140 |
Why?
|
Mosaicism | 2 | 2019 | 442 | 0.140 |
Why?
|
Mice, Inbred BALB C | 2 | 2018 | 6397 | 0.140 |
Why?
|
Receptor, EphA4 | 2 | 2006 | 18 | 0.140 |
Why?
|
Congresses as Topic | 1 | 2021 | 760 | 0.140 |
Why?
|
Databases, Genetic | 1 | 2023 | 1777 | 0.140 |
Why?
|
Vascular Malformations | 1 | 2022 | 442 | 0.140 |
Why?
|
Cell Line | 8 | 2021 | 15987 | 0.140 |
Why?
|
Segmental Duplications, Genomic | 1 | 2016 | 19 | 0.140 |
Why?
|
Allosteric Regulation | 1 | 2017 | 407 | 0.140 |
Why?
|
Ribonuclease III | 1 | 2018 | 275 | 0.140 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2010 | 625 | 0.140 |
Why?
|
Amino Acids | 1 | 2022 | 1727 | 0.140 |
Why?
|
Cell Respiration | 1 | 2016 | 203 | 0.140 |
Why?
|
Microscopy, Atomic Force | 1 | 2016 | 248 | 0.140 |
Why?
|
Diencephalon | 1 | 1995 | 56 | 0.140 |
Why?
|
Angiofibroma | 1 | 2016 | 68 | 0.130 |
Why?
|
Apnea | 1 | 2017 | 196 | 0.130 |
Why?
|
Cerebellar Diseases | 1 | 2018 | 226 | 0.130 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2017 | 191 | 0.130 |
Why?
|
GABA Agents | 1 | 2015 | 42 | 0.130 |
Why?
|
Coma | 2 | 2017 | 471 | 0.130 |
Why?
|
Basal Ganglia | 1 | 2018 | 547 | 0.130 |
Why?
|
Brain Waves | 1 | 2020 | 401 | 0.130 |
Why?
|
Albinism | 1 | 2015 | 27 | 0.130 |
Why?
|
Facial Neoplasms | 1 | 2016 | 121 | 0.130 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2013 | 1213 | 0.130 |
Why?
|
Microscopy | 1 | 2020 | 899 | 0.130 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2016 | 302 | 0.130 |
Why?
|
Frameshift Mutation | 1 | 2017 | 398 | 0.130 |
Why?
|
Huntington Disease | 1 | 2022 | 1109 | 0.130 |
Why?
|
Age of Onset | 3 | 2021 | 3263 | 0.130 |
Why?
|
3' Untranslated Regions | 2 | 2014 | 508 | 0.130 |
Why?
|
Vulnerable Populations | 1 | 2020 | 685 | 0.130 |
Why?
|
Immunoprecipitation | 1 | 2017 | 903 | 0.130 |
Why?
|
rho GTP-Binding Proteins | 3 | 2005 | 292 | 0.120 |
Why?
|
Animals, Newborn | 6 | 2010 | 2732 | 0.120 |
Why?
|
Receptor, EphA7 | 1 | 2014 | 7 | 0.120 |
Why?
|
Cell Size | 3 | 2012 | 641 | 0.120 |
Why?
|
Adult | 21 | 2023 | 213394 | 0.120 |
Why?
|
p120 GTPase Activating Protein | 1 | 2014 | 39 | 0.120 |
Why?
|
Down-Regulation | 2 | 2020 | 2999 | 0.120 |
Why?
|
Injections, Intraperitoneal | 1 | 2014 | 423 | 0.120 |
Why?
|
Presynaptic Terminals | 1 | 2016 | 303 | 0.120 |
Why?
|
Gene Knockdown Techniques | 3 | 2014 | 1654 | 0.120 |
Why?
|
Pattern Recognition, Automated | 2 | 2012 | 1000 | 0.120 |
Why?
|
Receptor, EphB4 | 1 | 2014 | 38 | 0.120 |
Why?
|
Imidazoles | 2 | 2017 | 1207 | 0.120 |
Why?
|
Exodeoxyribonucleases | 1 | 2015 | 176 | 0.120 |
Why?
|
Cytoskeletal Proteins | 1 | 2020 | 1369 | 0.120 |
Why?
|
Mutation, Missense | 2 | 2017 | 2552 | 0.120 |
Why?
|
Neurites | 1 | 2016 | 378 | 0.120 |
Why?
|
Prospective Studies | 15 | 2023 | 53037 | 0.120 |
Why?
|
Association Learning | 1 | 2015 | 224 | 0.120 |
Why?
|
Aging | 3 | 2020 | 8613 | 0.120 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 4743 | 0.120 |
Why?
|
Atrophy | 2 | 2013 | 1571 | 0.110 |
Why?
|
Electroretinography | 1 | 2015 | 511 | 0.110 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2015 | 207 | 0.110 |
Why?
|
Small-Conductance Calcium-Activated Potassium Channels | 1 | 2013 | 45 | 0.110 |
Why?
|
Social Environment | 1 | 2018 | 1014 | 0.110 |
Why?
|
Oligodendroglia | 1 | 2017 | 519 | 0.110 |
Why?
|
Riluzole | 1 | 2013 | 55 | 0.110 |
Why?
|
Imaging, Three-Dimensional | 3 | 2018 | 4035 | 0.110 |
Why?
|
Peroxisomes | 1 | 2013 | 58 | 0.110 |
Why?
|
Rats, Sprague-Dawley | 5 | 2015 | 8299 | 0.110 |
Why?
|
Mitochondria | 3 | 2020 | 3522 | 0.110 |
Why?
|
Oligonucleotides, Antisense | 1 | 2015 | 432 | 0.110 |
Why?
|
Retina | 2 | 2017 | 2633 | 0.110 |
Why?
|
Hydrocephalus | 1 | 1999 | 744 | 0.110 |
Why?
|
Rotarod Performance Test | 1 | 2012 | 63 | 0.110 |
Why?
|
Introns | 1 | 2015 | 992 | 0.110 |
Why?
|
Hypothalamus | 1 | 2018 | 1066 | 0.110 |
Why?
|
Ubiquitination | 1 | 2017 | 1003 | 0.110 |
Why?
|
Cross-Sectional Studies | 7 | 2023 | 24714 | 0.110 |
Why?
|
Temporal Lobe | 1 | 2020 | 1671 | 0.110 |
Why?
|
Time Factors | 6 | 2020 | 40050 | 0.110 |
Why?
|
Cohort Studies | 8 | 2022 | 40389 | 0.100 |
Why?
|
Mice, Mutant Strains | 1 | 2015 | 1883 | 0.100 |
Why?
|
Hand | 1 | 2017 | 875 | 0.100 |
Why?
|
Cytosol | 1 | 2015 | 902 | 0.100 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2020 | 1574 | 0.100 |
Why?
|
Retinal Pigment Epithelium | 1 | 2015 | 302 | 0.100 |
Why?
|
Receptors, Muscarinic | 1 | 1992 | 156 | 0.100 |
Why?
|
Microfilament Proteins | 1 | 2017 | 1150 | 0.100 |
Why?
|
Receptors, Opioid | 1 | 1992 | 155 | 0.100 |
Why?
|
Gene Knockout Techniques | 2 | 2012 | 803 | 0.100 |
Why?
|
Stem Cell Factor | 1 | 2012 | 219 | 0.100 |
Why?
|
Animals, Genetically Modified | 2 | 2020 | 1539 | 0.100 |
Why?
|
Contrast Media | 1 | 2005 | 5293 | 0.100 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2015 | 3922 | 0.100 |
Why?
|
Genes | 1 | 2015 | 1898 | 0.100 |
Why?
|
Sequence Deletion | 1 | 2016 | 1528 | 0.100 |
Why?
|
Cell Shape | 1 | 2012 | 375 | 0.100 |
Why?
|
Clinical Trials as Topic | 3 | 2016 | 7897 | 0.100 |
Why?
|
Immunohistochemistry | 4 | 2017 | 11347 | 0.100 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2015 | 617 | 0.100 |
Why?
|
Transfection | 3 | 2015 | 5884 | 0.100 |
Why?
|
Neovascularization, Pathologic | 1 | 2021 | 2639 | 0.100 |
Why?
|
Reflex | 1 | 2012 | 359 | 0.100 |
Why?
|
Metabolic Networks and Pathways | 1 | 2015 | 781 | 0.100 |
Why?
|
N-Methylaspartate | 1 | 2011 | 231 | 0.100 |
Why?
|
Immunity, Active | 1 | 2010 | 60 | 0.100 |
Why?
|
Neuropsychological Tests | 6 | 2023 | 6963 | 0.100 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2014 | 689 | 0.100 |
Why?
|
Amygdala | 1 | 2018 | 1303 | 0.090 |
Why?
|
Proteomics | 1 | 2024 | 3584 | 0.090 |
Why?
|
Trisomy | 1 | 2012 | 264 | 0.090 |
Why?
|
Goals | 1 | 2016 | 702 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2124 | 0.090 |
Why?
|
Apoptosis | 5 | 2012 | 9714 | 0.090 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2012 | 300 | 0.090 |
Why?
|
Prenatal Diagnosis | 2 | 2008 | 1227 | 0.090 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2015 | 788 | 0.090 |
Why?
|
GPI-Linked Proteins | 1 | 2011 | 433 | 0.090 |
Why?
|
Cerebellar Cortex | 1 | 1990 | 121 | 0.090 |
Why?
|
HEK293 Cells | 3 | 2014 | 4174 | 0.090 |
Why?
|
Genetic Engineering | 1 | 2016 | 955 | 0.090 |
Why?
|
Cataract | 1 | 2015 | 825 | 0.090 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2010 | 141 | 0.090 |
Why?
|
Interpersonal Relations | 1 | 2017 | 1421 | 0.090 |
Why?
|
Family Health | 1 | 2015 | 1281 | 0.090 |
Why?
|
Transcription Factor CHOP | 1 | 2009 | 73 | 0.090 |
Why?
|
Neoplasms, Experimental | 1 | 2014 | 1280 | 0.090 |
Why?
|
Tunicamycin | 1 | 2009 | 111 | 0.090 |
Why?
|
Image Enhancement | 3 | 2015 | 2928 | 0.080 |
Why?
|
Echinococcus granulosus | 1 | 2008 | 10 | 0.080 |
Why?
|
Ephrins | 2 | 2005 | 27 | 0.080 |
Why?
|
Glucose Transporter Type 1 | 1 | 2009 | 193 | 0.080 |
Why?
|
Lentivirus | 1 | 2012 | 501 | 0.080 |
Why?
|
Arthrogryposis | 1 | 2009 | 72 | 0.080 |
Why?
|
Echinococcosis, Hepatic | 1 | 2008 | 24 | 0.080 |
Why?
|
Treatment Outcome | 10 | 2022 | 62693 | 0.080 |
Why?
|
Chimerin 1 | 1 | 2008 | 14 | 0.080 |
Why?
|
Pyridines | 2 | 2017 | 2810 | 0.080 |
Why?
|
Models, Anatomic | 1 | 2013 | 690 | 0.080 |
Why?
|
Receptors, Nicotinic | 1 | 1992 | 496 | 0.080 |
Why?
|
Haploinsufficiency | 1 | 2010 | 327 | 0.080 |
Why?
|
Subtraction Technique | 1 | 2012 | 527 | 0.080 |
Why?
|
Threonine | 1 | 2009 | 274 | 0.080 |
Why?
|
Cell Count | 1 | 2012 | 1833 | 0.080 |
Why?
|
Pain | 1 | 2023 | 4923 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 480 | 0.080 |
Why?
|
Oncogene Protein v-akt | 1 | 2008 | 135 | 0.080 |
Why?
|
Sesquiterpenes | 1 | 2009 | 176 | 0.080 |
Why?
|
In Situ Hybridization | 4 | 2001 | 1934 | 0.080 |
Why?
|
Cytoplasmic Granules | 1 | 2011 | 610 | 0.080 |
Why?
|
Brain Mapping | 4 | 2021 | 6666 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 489 | 0.080 |
Why?
|
Zebrafish | 3 | 2020 | 2980 | 0.080 |
Why?
|
Video Recording | 3 | 2018 | 936 | 0.080 |
Why?
|
Hypopigmentation | 1 | 2008 | 41 | 0.080 |
Why?
|
Prefrontal Cortex | 1 | 2018 | 2138 | 0.080 |
Why?
|
Duane Retraction Syndrome | 1 | 2008 | 60 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2018 | 10945 | 0.080 |
Why?
|
Zebrafish Proteins | 1 | 2014 | 1005 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 3571 | 0.080 |
Why?
|
Motor Activity | 1 | 2017 | 2719 | 0.080 |
Why?
|
Syndrome | 3 | 2009 | 3241 | 0.080 |
Why?
|
Sex Factors | 1 | 2021 | 10398 | 0.070 |
Why?
|
Astrocytes | 2 | 2017 | 1258 | 0.070 |
Why?
|
Retinal Ganglion Cells | 2 | 2010 | 761 | 0.070 |
Why?
|
Psychotic Disorders | 1 | 2022 | 3028 | 0.070 |
Why?
|
Chick Embryo | 2 | 2008 | 978 | 0.070 |
Why?
|
Exercise | 1 | 2023 | 5591 | 0.070 |
Why?
|
Sleep | 2 | 2020 | 4596 | 0.070 |
Why?
|
Pattern Recognition, Visual | 1 | 2012 | 824 | 0.070 |
Why?
|
Pregnancy, High-Risk | 1 | 2007 | 120 | 0.070 |
Why?
|
Heme Oxygenase-1 | 1 | 2009 | 382 | 0.070 |
Why?
|
Lactones | 1 | 2009 | 329 | 0.070 |
Why?
|
Face | 1 | 2012 | 985 | 0.070 |
Why?
|
Models, Statistical | 3 | 2018 | 5113 | 0.070 |
Why?
|
Sensitivity and Specificity | 7 | 2017 | 14740 | 0.070 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2006 | 205 | 0.070 |
Why?
|
Retrospective Studies | 12 | 2022 | 76631 | 0.070 |
Why?
|
Tissue Engineering | 1 | 2016 | 1869 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2022 | 4014 | 0.070 |
Why?
|
Endoplasmic Reticulum | 2 | 2009 | 1141 | 0.070 |
Why?
|
Transduction, Genetic | 1 | 2009 | 916 | 0.070 |
Why?
|
Abnormalities, Multiple | 2 | 2011 | 1405 | 0.070 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2005 | 2833 | 0.070 |
Why?
|
Receptor Aggregation | 1 | 2005 | 80 | 0.070 |
Why?
|
Maternal Exposure | 1 | 2012 | 952 | 0.070 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2010 | 604 | 0.070 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4182 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15511 | 0.070 |
Why?
|
Visual Pathways | 1 | 2010 | 566 | 0.070 |
Why?
|
Serine | 1 | 2009 | 831 | 0.060 |
Why?
|
Transcription Factors | 5 | 2021 | 12120 | 0.060 |
Why?
|
Cytoplasm | 1 | 2010 | 1536 | 0.060 |
Why?
|
Caenorhabditis elegans | 2 | 2013 | 1412 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8605 | 0.060 |
Why?
|
Membrane Proteins | 2 | 2020 | 7862 | 0.060 |
Why?
|
Registries | 1 | 2020 | 8039 | 0.060 |
Why?
|
Neovascularization, Physiologic | 1 | 2012 | 1352 | 0.060 |
Why?
|
Organ Size | 3 | 2018 | 2247 | 0.060 |
Why?
|
Caregivers | 1 | 2016 | 2067 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2015 | 7709 | 0.060 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2006 | 432 | 0.060 |
Why?
|
Demyelinating Diseases | 1 | 2007 | 371 | 0.060 |
Why?
|
Bicuculline | 2 | 2016 | 99 | 0.060 |
Why?
|
Nervous System Malformations | 1 | 2006 | 244 | 0.060 |
Why?
|
Gene Deletion | 1 | 2012 | 2757 | 0.060 |
Why?
|
Middle Aged | 6 | 2023 | 212863 | 0.060 |
Why?
|
Consensus | 2 | 2023 | 2913 | 0.060 |
Why?
|
Parents | 3 | 2022 | 3368 | 0.060 |
Why?
|
Amino Acid Sequence | 5 | 2008 | 13816 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2014 | 3504 | 0.060 |
Why?
|
Flow Cytometry | 2 | 2016 | 5959 | 0.060 |
Why?
|
Melanoma | 1 | 2022 | 5446 | 0.060 |
Why?
|
Pregnancy | 4 | 2022 | 29002 | 0.060 |
Why?
|
Stress, Physiological | 1 | 2011 | 1405 | 0.060 |
Why?
|
Genes, Dominant | 2 | 2021 | 883 | 0.060 |
Why?
|
Intermediate Filaments | 1 | 2023 | 173 | 0.050 |
Why?
|
Nerve Regeneration | 1 | 2008 | 795 | 0.050 |
Why?
|
Blotting, Northern | 2 | 1995 | 1583 | 0.050 |
Why?
|
ROC Curve | 2 | 2021 | 3526 | 0.050 |
Why?
|
Poloxamer | 1 | 2022 | 58 | 0.050 |
Why?
|
Algorithms | 5 | 2018 | 13872 | 0.050 |
Why?
|
Paraplegia | 1 | 2023 | 166 | 0.050 |
Why?
|
DNA-Binding Proteins | 3 | 2021 | 9622 | 0.050 |
Why?
|
Psychometrics | 2 | 2023 | 2995 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5632 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 1 | 2011 | 3770 | 0.050 |
Why?
|
Prevalence | 4 | 2021 | 15153 | 0.050 |
Why?
|
Infant, Newborn, Diseases | 1 | 2008 | 578 | 0.050 |
Why?
|
Epigenesis, Genetic | 1 | 2015 | 3614 | 0.050 |
Why?
|
Retinoids | 1 | 2022 | 96 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3143 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3248 | 0.050 |
Why?
|
Pilot Projects | 3 | 2022 | 8275 | 0.050 |
Why?
|
Risk Factors | 5 | 2020 | 71974 | 0.050 |
Why?
|
Fatal Outcome | 1 | 2007 | 1850 | 0.050 |
Why?
|
Monoacylglycerol Lipases | 1 | 2022 | 48 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 6998 | 0.050 |
Why?
|
Gangliosides | 1 | 2022 | 140 | 0.050 |
Why?
|
Muscle Spasticity | 1 | 2022 | 154 | 0.050 |
Why?
|
Calpain | 1 | 2022 | 150 | 0.050 |
Why?
|
Mutant Proteins | 1 | 2023 | 500 | 0.050 |
Why?
|
Axonal Transport | 1 | 2022 | 179 | 0.050 |
Why?
|
Sphingolipids | 1 | 2022 | 160 | 0.050 |
Why?
|
Pentobarbital | 1 | 2001 | 155 | 0.050 |
Why?
|
Stereotyped Behavior | 1 | 2021 | 137 | 0.050 |
Why?
|
Cerebellar Nuclei | 1 | 2021 | 56 | 0.050 |
Why?
|
Fetal Proteins | 1 | 2001 | 93 | 0.050 |
Why?
|
Drug Therapy, Combination | 2 | 2001 | 6478 | 0.050 |
Why?
|
Cell Survival | 4 | 2012 | 5877 | 0.050 |
Why?
|
Endocytosis | 1 | 2005 | 984 | 0.050 |
Why?
|
United States | 5 | 2022 | 69573 | 0.050 |
Why?
|
Adaptor Protein Complex beta Subunits | 1 | 2020 | 13 | 0.050 |
Why?
|
Intelligence Tests | 1 | 2021 | 505 | 0.050 |
Why?
|
Brain Edema | 1 | 2005 | 617 | 0.050 |
Why?
|
Muscle Hypotonia | 1 | 2021 | 163 | 0.050 |
Why?
|
Anesthesia | 1 | 2011 | 1543 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2010 | 2948 | 0.050 |
Why?
|
Cytoskeleton | 1 | 2005 | 1181 | 0.040 |
Why?
|
Midazolam | 1 | 2001 | 270 | 0.040 |
Why?
|
Actins | 2 | 2005 | 2112 | 0.040 |
Why?
|
Centrioles | 1 | 2020 | 79 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15036 | 0.040 |
Why?
|
Globus Pallidus | 1 | 2021 | 253 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2012 | 4454 | 0.040 |
Why?
|
Polymerase Chain Reaction | 3 | 2011 | 6174 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2023 | 429 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2016 | 5128 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 423 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2010 | 3433 | 0.040 |
Why?
|
Fibroblasts | 3 | 2020 | 4137 | 0.040 |
Why?
|
Anesthetics, Intravenous | 1 | 2001 | 417 | 0.040 |
Why?
|
Intelligence | 1 | 2023 | 919 | 0.040 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 1999 | 194 | 0.040 |
Why?
|
Hallucinations | 1 | 2000 | 359 | 0.040 |
Why?
|
Dependovirus | 1 | 2023 | 710 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2009 | 3615 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2019 | 21694 | 0.040 |
Why?
|
Hedgehog Proteins | 1 | 2022 | 774 | 0.040 |
Why?
|
Biological Assay | 1 | 2021 | 653 | 0.040 |
Why?
|
Hemodiafiltration | 1 | 2017 | 20 | 0.040 |
Why?
|
Telemetry | 1 | 2018 | 204 | 0.040 |
Why?
|
Drug Resistance | 1 | 2003 | 1610 | 0.040 |
Why?
|
Subcellular Fractions | 1 | 2018 | 547 | 0.040 |
Why?
|
Photic Stimulation | 2 | 2015 | 2032 | 0.040 |
Why?
|
Health Priorities | 1 | 2020 | 380 | 0.040 |
Why?
|
Learning | 2 | 2019 | 1695 | 0.040 |
Why?
|
Facies | 1 | 2017 | 195 | 0.040 |
Why?
|
Prognosis | 4 | 2018 | 28901 | 0.040 |
Why?
|
Language | 2 | 2019 | 1447 | 0.040 |
Why?
|
Los Angeles | 1 | 2017 | 236 | 0.040 |
Why?
|
Decontamination | 1 | 2017 | 69 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 13635 | 0.040 |
Why?
|
Germ Cells | 1 | 2021 | 627 | 0.040 |
Why?
|
2-Amino-5-phosphonovalerate | 1 | 2016 | 62 | 0.040 |
Why?
|
Protein Kinase C | 1 | 2021 | 1223 | 0.040 |
Why?
|
DNA Primers | 2 | 2008 | 2893 | 0.040 |
Why?
|
Fibroblast Growth Factors | 1 | 2022 | 879 | 0.040 |
Why?
|
Pregnancy Complications | 1 | 2010 | 2867 | 0.040 |
Why?
|
Plasmapheresis | 1 | 2017 | 212 | 0.040 |
Why?
|
Neuroglia | 1 | 2022 | 928 | 0.040 |
Why?
|
Long-Term Synaptic Depression | 1 | 2016 | 58 | 0.030 |
Why?
|
Immune System | 1 | 2022 | 801 | 0.030 |
Why?
|
Cycloheximide | 1 | 2016 | 347 | 0.030 |
Why?
|
Zinc Fingers | 1 | 1998 | 581 | 0.030 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 3 | 1 | 1995 | 4 | 0.030 |
Why?
|
Wavelet Analysis | 1 | 2015 | 57 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2020 | 38942 | 0.030 |
Why?
|
Conditioning, Eyelid | 1 | 2015 | 10 | 0.030 |
Why?
|
Microscopy, Confocal | 2 | 2016 | 1967 | 0.030 |
Why?
|
Dendrites | 2 | 2009 | 488 | 0.030 |
Why?
|
Gestational Age | 2 | 1995 | 3486 | 0.030 |
Why?
|
Ligands | 2 | 2014 | 3311 | 0.030 |
Why?
|
Information Theory | 1 | 2015 | 51 | 0.030 |
Why?
|
Elastic Modulus | 1 | 2016 | 213 | 0.030 |
Why?
|
Comorbidity | 2 | 2021 | 10362 | 0.030 |
Why?
|
Computer Simulation | 3 | 2015 | 6237 | 0.030 |
Why?
|
Affect | 1 | 2023 | 1475 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2022 | 1015 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2021 | 12237 | 0.030 |
Why?
|
Propofol | 1 | 2001 | 626 | 0.030 |
Why?
|
Sickness Impact Profile | 1 | 2016 | 305 | 0.030 |
Why?
|
Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2014 | 13 | 0.030 |
Why?
|
Thalamic Nuclei | 1 | 1995 | 115 | 0.030 |
Why?
|
Mice, Nude | 1 | 2021 | 3692 | 0.030 |
Why?
|
Growth Substances | 1 | 2017 | 784 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2001 | 1453 | 0.030 |
Why?
|
Testis | 1 | 1998 | 799 | 0.030 |
Why?
|
Motion | 1 | 2018 | 803 | 0.030 |
Why?
|
Ephrin-A5 | 1 | 2014 | 16 | 0.030 |
Why?
|
Glutathione | 1 | 2017 | 585 | 0.030 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2016 | 374 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2020 | 1082 | 0.030 |
Why?
|
Periventricular Nodular Heterotopia | 1 | 2014 | 57 | 0.030 |
Why?
|
DNA, Complementary | 2 | 1998 | 2049 | 0.030 |
Why?
|
Antisense Elements (Genetics) | 1 | 1993 | 37 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2022 | 1584 | 0.030 |
Why?
|
Dark Adaptation | 1 | 2015 | 220 | 0.030 |
Why?
|
RNA Probes | 1 | 1993 | 112 | 0.030 |
Why?
|
Microtubules | 1 | 2020 | 1088 | 0.030 |
Why?
|
Muscular Dystrophy, Animal | 1 | 2014 | 91 | 0.030 |
Why?
|
Metabolomics | 1 | 2022 | 1460 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2019 | 554 | 0.030 |
Why?
|
Molecular Sequence Data | 4 | 2008 | 18125 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2023 | 3419 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2023 | 5058 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2001 | 1659 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 3 | 2008 | 20055 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2019 | 789 | 0.030 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2015 | 537 | 0.030 |
Why?
|
Insulin | 1 | 2008 | 6569 | 0.030 |
Why?
|
Statistical Distributions | 1 | 2013 | 64 | 0.030 |
Why?
|
Coronary Angiography | 1 | 2005 | 4560 | 0.030 |
Why?
|
Histology | 1 | 2012 | 17 | 0.030 |
Why?
|
Embryonic and Fetal Development | 1 | 1993 | 438 | 0.030 |
Why?
|
Acute Disease | 1 | 2003 | 7128 | 0.030 |
Why?
|
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 1992 | 36 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2001 | 4935 | 0.030 |
Why?
|
Synapsins | 1 | 2012 | 43 | 0.030 |
Why?
|
RNA Interference | 2 | 2012 | 2899 | 0.030 |
Why?
|
Base Sequence | 3 | 2008 | 12804 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12948 | 0.030 |
Why?
|
Two-Hybrid System Techniques | 2 | 2005 | 464 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2017 | 1186 | 0.030 |
Why?
|
Self Report | 1 | 2023 | 3524 | 0.030 |
Why?
|
Enkephalins | 1 | 1992 | 154 | 0.030 |
Why?
|
Survival | 1 | 2012 | 162 | 0.030 |
Why?
|
Wakefulness | 1 | 2018 | 1241 | 0.030 |
Why?
|
Pyramidal Cells | 1 | 2014 | 357 | 0.030 |
Why?
|
RNA | 1 | 2021 | 2723 | 0.020 |
Why?
|
Biopsy | 1 | 2003 | 6722 | 0.020 |
Why?
|
Iron | 1 | 2020 | 1776 | 0.020 |
Why?
|
Language Disorders | 1 | 2012 | 140 | 0.020 |
Why?
|
Autoradiography | 1 | 1992 | 765 | 0.020 |
Why?
|
Sodium Compounds | 1 | 2011 | 30 | 0.020 |
Why?
|
src-Family Kinases | 1 | 2014 | 549 | 0.020 |
Why?
|
Receptors, Opioid, mu | 1 | 1992 | 179 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2016 | 1769 | 0.020 |
Why?
|
Motor Skills | 1 | 2014 | 520 | 0.020 |
Why?
|
Gene Expression Profiling | 3 | 2014 | 9387 | 0.020 |
Why?
|
Arsenites | 1 | 2011 | 66 | 0.020 |
Why?
|
Horseradish Peroxidase | 1 | 1990 | 169 | 0.020 |
Why?
|
CA1 Region, Hippocampal | 1 | 2011 | 113 | 0.020 |
Why?
|
Vision, Ocular | 1 | 2014 | 471 | 0.020 |
Why?
|
Disease Progression | 2 | 2019 | 13237 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1992 | 2198 | 0.020 |
Why?
|
Gene Library | 1 | 1993 | 1077 | 0.020 |
Why?
|
Sample Size | 1 | 2014 | 845 | 0.020 |
Why?
|
Benzamides | 1 | 2016 | 1374 | 0.020 |
Why?
|
PC12 Cells | 1 | 2011 | 330 | 0.020 |
Why?
|
Poly I-C | 1 | 2010 | 115 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2881 | 0.020 |
Why?
|
Organ Specificity | 1 | 1995 | 2004 | 0.020 |
Why?
|
Cytoprotection | 1 | 2011 | 208 | 0.020 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2011 | 189 | 0.020 |
Why?
|
Carbohydrate Metabolism, Inborn Errors | 1 | 2009 | 31 | 0.020 |
Why?
|
Adenylate Kinase | 1 | 2010 | 100 | 0.020 |
Why?
|
HeLa Cells | 2 | 2006 | 3119 | 0.020 |
Why?
|
Dentate Gyrus | 1 | 2010 | 160 | 0.020 |
Why?
|
Artifacts | 1 | 2018 | 1905 | 0.020 |
Why?
|
Exploratory Behavior | 1 | 2010 | 270 | 0.020 |
Why?
|
Cats | 1 | 1990 | 1000 | 0.020 |
Why?
|
Lithium Chloride | 1 | 2009 | 87 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5948 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2017 | 2015 | 0.020 |
Why?
|
Golgi Apparatus | 1 | 1990 | 410 | 0.020 |
Why?
|
Nerve Crush | 1 | 2008 | 80 | 0.020 |
Why?
|
Chemotaxis | 1 | 2012 | 602 | 0.020 |
Why?
|
Axotomy | 1 | 2008 | 75 | 0.020 |
Why?
|
Abducens Nerve | 1 | 2008 | 28 | 0.020 |
Why?
|
Ribosomal Protein S6 | 1 | 2008 | 70 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2014 | 867 | 0.020 |
Why?
|
Granulocytes | 1 | 1990 | 545 | 0.020 |
Why?
|
Isoenzymes | 1 | 1993 | 1720 | 0.020 |
Why?
|
Light | 1 | 2015 | 1380 | 0.020 |
Why?
|
Angelman Syndrome | 1 | 2010 | 136 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2022 | 11985 | 0.020 |
Why?
|
Oculomotor Nerve | 1 | 2008 | 74 | 0.020 |
Why?
|
Blood Vessels | 1 | 2014 | 1126 | 0.020 |
Why?
|
Genome, Human | 1 | 2021 | 4419 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2009 | 641 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2011 | 2665 | 0.020 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2009 | 526 | 0.020 |
Why?
|
Phenylbutyrates | 1 | 2008 | 69 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2017 | 1780 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9846 | 0.020 |
Why?
|
Homozygote | 1 | 2012 | 1788 | 0.020 |
Why?
|
eIF-2 Kinase | 1 | 2008 | 148 | 0.020 |
Why?
|
DNA | 1 | 2021 | 7275 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2015 | 2504 | 0.020 |
Why?
|
Risk Assessment | 2 | 2020 | 23294 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2017 | 6610 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2016 | 1744 | 0.020 |
Why?
|
Hydrogen Peroxide | 1 | 2011 | 730 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2014 | 1548 | 0.020 |
Why?
|
Nicotine | 1 | 1992 | 670 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2008 | 2910 | 0.020 |
Why?
|
Electroporation | 1 | 2008 | 250 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2007 | 426 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8307 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9684 | 0.020 |
Why?
|
Reaction Time | 1 | 2012 | 2097 | 0.020 |
Why?
|
Pyrazoles | 1 | 2016 | 1963 | 0.020 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2008 | 563 | 0.020 |
Why?
|
Disease Management | 1 | 2016 | 2448 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13402 | 0.020 |
Why?
|
Optic Nerve | 1 | 2008 | 558 | 0.020 |
Why?
|
Cell Death | 1 | 2011 | 1693 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2022 | 4426 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3138 | 0.020 |
Why?
|
Oculomotor Muscles | 1 | 2008 | 355 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2704 | 0.020 |
Why?
|
Patch-Clamp Techniques | 1 | 2006 | 958 | 0.010 |
Why?
|
Neoplasms | 2 | 2010 | 21507 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 2006 | 797 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2006 | 853 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5652 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2727 | 0.010 |
Why?
|
Genetic Techniques | 1 | 2006 | 436 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9314 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2017 | 3497 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 2008 | 1096 | 0.010 |
Why?
|
Embryonic Stem Cells | 1 | 2010 | 1294 | 0.010 |
Why?
|
Autoantibodies | 1 | 2011 | 2020 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2007 | 1157 | 0.010 |
Why?
|
Hypoglycemia | 1 | 2009 | 855 | 0.010 |
Why?
|
Aged | 3 | 2022 | 162698 | 0.010 |
Why?
|
Protein Binding | 1 | 2013 | 9375 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2006 | 3701 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8274 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2006 | 2634 | 0.010 |
Why?
|
Cell Membrane | 1 | 2008 | 3747 | 0.010 |
Why?
|
Body Weight | 1 | 2009 | 4660 | 0.010 |
Why?
|
Cell Communication | 1 | 2005 | 1618 | 0.010 |
Why?
|
Immunoblotting | 1 | 2001 | 1683 | 0.010 |
Why?
|
Brain Chemistry | 1 | 2001 | 985 | 0.010 |
Why?
|
Spermatogenesis | 1 | 1998 | 264 | 0.010 |
Why?
|
Spinal Cord | 1 | 2005 | 1818 | 0.010 |
Why?
|
Eye | 1 | 2001 | 731 | 0.010 |
Why?
|
Skin | 1 | 2009 | 4324 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2001 | 4319 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2006 | 4791 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2008 | 3858 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2001 | 3848 | 0.010 |
Why?
|
Phylogeny | 1 | 2001 | 2789 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1990 | 9259 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2009 | 10455 | 0.010 |
Why?
|
Survival Rate | 1 | 2007 | 12761 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2008 | 15194 | 0.000 |
Why?
|